Open navigation
Search

Patent Litigation & Arbitration

There is a growing uptake in the use of arbitration in the context of patent disputes, in particular those relating to Standard Essential Patents (SEPs) that necessarily involve Fair Reasonable and Non-Discriminatory (FRAND) licence terms. In fact, despite the UK court being willing and able to deal with international FRAND licensing disputes, the judges are themselves proposing arbitration as an alternative, and in many respects, more advantageous form for such disputes in the future (see our recent LawNow on this topic here).

In this arbitration/patent litigation space, CMS are ideally placed to advise international businesses and to assist with the successful conclusion of arbitrations in this complex and highly specialised space. Our arbitration team has a significant track record in international arbitration, from advising on the drafting of arbitration agreements through the conduct of the arbitral process to enforcing arbitration awards, whilst our Patent litigation team has extensive experience advising clients on both the technical and FRAND aspects of patent licensing disputes (in arbitration and High Court litigation, including at the Supreme Court).

Furthermore, the commencement of the Unified Patent Court (UPC) next year brings with it the Unified Patent Court Arbitration and Mediation Centre. CMS are again ideally placed to advise and act in this UPC context given its combined Litigation and Patent Prosecution teams already advising clients in relation to this new forum.  

CMS not only has this experience in London but across its impressive international network. This means that no matter where (and under what rules) the arbitration may be brought, CMS will have both global and local expertise to fight for the best outcome for our clients.


Back to Patents

Explore more

EU Pharma Package: New incentives for innovation in antibiotics

EU Pharma Package: New incentives for innovation in antibiotics

25 Aug 2026 7 min read
EU Pharma Package: Regulatory data and market protection

EU Pharma Package: Regulatory data and market protection

14 Aug 2026 13 min read
Stability as strategy: The UK’s regulatory position in the wake of the EU Pharmaceutical Package

Stability as strategy: The UK’s regulatory position in the wake of the EU Pharmaceutical Package

15 Jul 2026 7 min read
UK patent practice note about search and examination in the light of Emotional Perception AI

UK patent practice note about search and examination in the light of Emotional Perception AI

15 Jul 2026 7 min read
UK Clinical Trial Transparency and Patent Strategy

UK Clinical Trial Transparency and Patent Strategy

13 Jul 2026 12 min read
The Post-Quantum Future

The Post-Quantum Future

29 May 2026 5 min read
DABUS at the European Patent Office: who can be named as the inventor when AI creates something?

DABUS at the European Patent Office: who can be named as the inventor when AI creates something?

20 Apr 2026 4 min read
Brevity versus giving away the crown jewels: getting the balance right for protecting machine learning technology with patents

Brevity versus giving away the crown jewels: getting the balance right for protecting machine learning technology with patents

25 Feb 2026 5 min read

Events

  • 17 Mar 2026 - 26 Jan 2027
  • 08 Sep 2026 - 01 Dec 2026
  • 10 Sep 2026 - 04 Nov 2026
  • 05 Oct 2026
  • 06 Oct 2026
  • 06 Oct 2026
  • 06 Oct 2026 - 25 Nov 2026
  • 07 Oct 2026 - 10 Oct 2026
  • 07 Oct 2026 - 10 Oct 2026
  • 19 Oct 2026
  • 09 Nov 2026
  • 23 Nov 2026
  • 07 Dec 2026

Local market knowledge. Global outlook

We provide future-facing legal advice to help your organisation thrive. Combining local market knowledge and a global perspective, and with lawyers in locations worldwide, your organisation benefits from the expertise it needs, even across borders.

About CMS
People across CMS Find a Lawyer
10,000+ Staff
7,400+ Lawyers
Locations across CMS Find an office
50+ Countries
90+ Offices
22 Member firms
Back to top Back to top
Opens in new window